Application of a compound in inhibiting the Xa factor

A novel small molecule compound with a unique skeleton (CAS: 1563958-97-3) was designed using a mixed integer nonlinear programming model, which solved the problem of high structural similarity among existing factor Xa inhibitors, achieved highly efficient factor Xa inhibition, and promoted the development of novel anticoagulant drugs.

CN117860737BActive Publication Date: 2026-07-17DALIAN UNIV OF TECH

Patent Information

Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
DALIAN UNIV OF TECH
Filing Date
2024-01-09
Publication Date
2026-07-17

Smart Images

  • Figure CN117860737B_ABST
    Figure CN117860737B_ABST
Patent Text Reader

Abstract

This invention relates to the field of biomedical technology, and more particularly to the application of a compound in inhibiting factor Xa. Specifically, this compound was designed using a de novo drug design framework based on mathematical programming methods and deep learning models, and its in vitro activity was verified, demonstrating sub-micromolar activity against factor Xa, making it suitable for manufacturing candidate drugs for diseases related to factor Xa.
Need to check novelty before this filing date? Find Prior Art